期刊文献+

Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess:a prospective study 被引量:8

Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess:a prospective study
下载PDF
导出
摘要 Biochemical or clinical changes of hyperandrogenism are important elements of polycystic ovary syndrome (PCOS). There is currently no consensus on the definition and diagnostic criteria of hyperandrogenism in PCOS. The aim of this study was to investigate the complex symptoms of hyperandrogenic disorders and the correlations between metabolism and hyperandrogenism in patients with PCOS from an outpatient reproductive medicine clinic in China. We conducted a case control study of 125 PCOS patients and 130 controls to evaluate differences in body mass index (BMI), total testosterone (TT), modified Ferriman-Gallwey hirsutism score, sex hormone binding globulin (SHBG), homeostasis model assessment-estimated insulin resistance (HOMA-IR) and free androgen index (FAI) between PCOS patients and controls and subgroups of PCOS. The prevalence of acne and hirsutism did not differ significantly between the hyperandrogenic and non-hyperandrogenic subgroup. Patients with signs of hyper- androgenism had significantly higher BMI (P 〈 0.05), but differences in TT, SHBG, FAI and waist/hip ratio were insignificant. The odds ratio of overweight was calculated for all PCOS patients. Our results suggest that PCOS patients with high BMI tend to have functional disorders of androgen excess; therefore, BMI may be a strong pre-dictor of hyperandrogenism in PCOS. Biochemical or clinical changes of hyperandrogenism are important elements of polycystic ovary syndrome (PCOS). There is currently no consensus on the definition and diagnostic criteria of hyperandrogenism in PCOS. The aim of this study was to investigate the complex symptoms of hyperandrogenic disorders and the correlations between metabolism and hyperandrogenism in patients with PCOS from an outpatient reproductive medicine clinic in China. We conducted a case control study of 125 PCOS patients and 130 controls to evaluate differences in body mass index (BMI), total testosterone (TT), modified Ferriman-Gallwey hirsutism score, sex hormone binding globulin (SHBG), homeostasis model assessment-estimated insulin resistance (HOMA-IR) and free androgen index (FAI) between PCOS patients and controls and subgroups of PCOS. The prevalence of acne and hirsutism did not differ significantly between the hyperandrogenic and non-hyperandrogenic subgroup. Patients with signs of hyper- androgenism had significantly higher BMI (P 〈 0.05), but differences in TT, SHBG, FAI and waist/hip ratio were insignificant. The odds ratio of overweight was calculated for all PCOS patients. Our results suggest that PCOS patients with high BMI tend to have functional disorders of androgen excess; therefore, BMI may be a strong pre-dictor of hyperandrogenism in PCOS.
出处 《The Journal of Biomedical Research》 CAS CSCD 2016年第3期197-202,共6页 生物医学研究杂志(英文版)
基金 supported by grants from the Major State Basic Research Development Program of China(973 Program:No.2012CB944902 and No.2012CB944703) the National Natural Science Foundation of China(No.30801236) the Priority Academic Program Development of Jiangsu Higher Education Institutions
关键词 polycystic ovary syndrome diagnostic criteria OBESITY reproductive health long-term weight polycystic ovary syndrome, diagnostic criteria, obesity, reproductive health, long-term weight
  • 相关文献

参考文献31

  • 1Clark NM, Podolski A J, Brooks ED, et al. Prevalence of polycystic ovary syndrome phenotypes using updated cri- teria for polycystic ovarian morphology: an assessment of over 100 consecutive women self-reporting features of polycystic ovary syndrome[J]. Reprod Sci, 2014,21: 1034-1043.
  • 2Revised 2003 consensus on diagnostic criteria and long- term health risks related to polycystic ovary syndrome[J]. Fertil Steril, 2004,81 : 19-25.
  • 3Albu A, Radian S, Fica S, et al. Biochemical hyperan- drogenism is associated with metabolic syndrome inde- pendently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients[J]. Endocrine, 2014.
  • 4Epub ahead of print. Huang A, Brennan K, Azziz R. Prevalence of hyperandro- genemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria[J]. Fertil Steril, 2010,93:1938-1941.
  • 5O'Reilly MW, Taylor AE, Crabtree N J, et al. androstenedi- one[J]. J Clin Endocrinol Metab, 2014,99:1027-1036.
  • 6Voutilainen R, Jaaskelainen J. Premature adrenarche: Etiology, clinical findings, and consequences[J]. J Steroid Biochem Mol Biol, 2014.
  • 7Epub ahead of print. Demir B, Pasa S, Demir S, et al. Hirsutism score and the severity of hyperandrogenism associated with polycystic ovary syndrome in the southeastern region of Turkey[J]. J lnt Med Res, 2011,39:1529-1535.
  • 8Ozdemir S, Ozdemir M, Gorkemli H, et al. Specific der- matologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism[J]. Acta Obstet Gynecol Scand, 2010,89:199-204.
  • 9Hart R, Hickey M, Franks S. Definitions, prevalence and symp- toms of polycystic ovaries and polycystic ovary syndrome[J]. Best Pract Res Clin Obstet Gynaecol, 2004,18:671-683.
  • 10Solomon A, Norton GR, Woodiwiss A J, et al. Obesity and carotid atherosclerosis in African black and Caucasian women with established rheumatoid arthritis: a cross- sectional study[J]. Arthritis Res Ther, 2012,14:R67.

同被引文献50

引证文献8

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部